Quality of Life among Epileptic Patients after Vagus Nerve Stimulator Implan tation: A Cross-Sectional Study

Authors

  • Abdel Fattah Atallah Turke BSN, Ministry of Health and Environment, Anbar Health Directorate / Al-Amriya General Hospital, Anbar.
  • Haider Mohammed Majeed PhD Nursing, assistant professor, Department of Adult Nursing, College of Nursing, University of Baghdad, Baghdad, Iraq.

DOI:

https://doi.org/10.48165/jiafm.2024.46.1(Suppl).24

Keywords:

Quality of Life, Epileptic patient, and Vagus nerve stimulator

Abstract

Globally, epilepsy affects people of all ages, races, social groups, and both sexes. Over 70 million individuals worldwide suffer from  epilepsy, one of the most prevalent and dangerous brain disorders. In cases where resective surgery is not feasible or the patient rejects  it, vagus nerve stimulation is a well-researched and efficacious technique for treating refractory epilepsy in addition to antiseizure  medication. This study aims to assess the quality of life for epileptic patients with vagus nerve stimulator implantation. A quantitative  cross-sectional design was conducted in outpatient clinics at Dr. Saad Al-Watari for Neurological Sciences Teaching Hospital and  Neurosugery Teaching Hospital at Baghdad Governorate. The study period extended from December 2023 to January 2024. Nonprob ability purposive sampling was used which included 1,000 patients visiting the outpatient clinics (epilepsy consultation). Data were  collected using a questionnaire from January to March 2024. The study instruments consisted of two parts. First, the demographic sheet  comprised sociodemographic information about the participants. The second part contained the evaluation of the standard of living for  epileptic patients. The collected data were examined using SPSS version 26. The study comprised 100 patients with an average age of  32 ± 10 years. The mean (QOL-SF-36) score was 2.20 ± .739. One hundred (54.8%) of participants had a moderate quality of life.The  study’s sample of epileptic patients had a moderate mean quality of life. Improved quality of life (QOL) is linked to VNS treatment for  drug-resistant epilepsy. 

Downloads

Download data is not yet available.

References

Abid, R., Majeed, H. and Mohammed, T. (2018) ‘Assessment of nurses documentation for nursing care at surgical wards in Baghdad teaching hospitals’, Journal of Pharmaceutical Sciences and Research, 10(10), pp. 2568–2571.

Baker, D., Eccles, F. J. R. and Caswell, H. L. (2018) ‘Correlates of stigma in adults with epilepsy: A systematic review of quantitative studies’, Epilepsy & Behavior, 83, pp. 67–80. doi: 10.1016/j.yebeh.2018.02.016.

Balestrini, S. et al. (2021) ‘The aetiologies of epilepsy’, Epileptic Disorders, 23(1), pp. 1–16. doi: 10.1684/ epd.2021.1255.

Batson, S. et al. (2022) ‘Efficacy and safety of VNS therapy or continued medication management for treatment of adults with drug-resistant epilepsy: systematic review and meta

analysis’, Journal of neurology. 2022/01/16 edn, 269(6), pp. 2874–2891. doi: 10.1007/s00415-022-10967-6.

Chen, H.-F. et al. (2016) ‘Factors affecting quality of life in adults with epilepsy in Taiwan: A cross-sectional, correlational study’, Epilepsy & Behavior, 58, pp. 26–32. doi: 10.1016/j.yebeh.2016.02.019.

Englot, D. J., Birk, H. and Chang, E. F. (2016) ‘Seizure outcomes in nonresective epilepsy surgery: an update’, Neurosurgical Review, 40(2), pp. 181–194. doi: 10.1007/ s10143-016-0725-8.

Espinosa Jovel, C. A. et al. (2016) ‘Factors associated with quality of life in a low-income population with epilepsy’, Epilepsy Research, 127, pp. 168–174. doi: 10.1016/j. eplepsyres.2016.08.031.

Fiest, K. M. et al. (2017) ‘Prevalence and incidence of epilepsy: A systematic review and meta-analysis of international studies’, Neurology, 88(3), pp. 296–303. doi: 10.1212/WNL.0000000000003509.

George, J., Kulkarni, C. and Sarma, G. R. K. (2015) ‘Antiepileptic drugs and quality of life in patients with epilepsy: a tertiary care hospital-based study’, Value in Health Regional Issues, 6, pp. 1–6. doi: 10.1016/j.vhri.2014.07.009.

Honari, B. et al. (2021) ‘Epilepsy and quality of life in Iranian epileptic patients’, Journal of patient-reported outcomes, 5(1), pp. 16–16. doi: 10.1186/s41687-021-00292-3.

Liu, G., Slater, N. and Perkins, A. (2017) ‘Epilepsy: treatment options’, American Family Physician, 96(2), pp. 87–96. 12. Majeed, H. et al. (2023) ‘Protective health behaviors among

critical care nurses concerning pressure ulcer prevention for hospitalized patients at Baghdad teaching hospitals’, Al Rafidain Journal of Medical Sciences, 5, pp. 205–210. doi: 10.54133/ajms.v5i.211.

Majeed, H. M. et al. (2023) ‘Evaluation of nurses’ practices and perceived barriers related to pain assessment in critically ill patients at Baghdad teaching hospitals’, Azerbaijan Pharmaceutical and Pharmacotherapy J, 22(1), pp. 64–69. doi: 10.61336/appj/22-1-14.

Majeed, H. M., Hassan, A. F. and Mousa, A. M. (2024) ‘Students’ knowledge and attitude concerning organ donation at Iraqi nursing colleges’, J Educ Health Promot, 13(1), p. 60. doi: 10.4103/jehp.jehp_845_23.

Milligan, T. A. (2021) ‘Epilepsy: a clinical overview’, The American Journal of Medicine, 134(7), pp. 840–847. doi: 10.1016/j.amjmed.2021.01.038.

Milovanović, M., Martinović, Ž. and Tošković, O. (2014) ‘Determinants of quality of life in people with epilepsy in Serbia’, Epilepsy & Behavior, 31, pp. 160–166. doi: 10.1016/j.yebeh.2013.12.015.

Nabukenya, A. M. et al. (2014) ‘Health-related quality of life in epilepsy patients receiving anti-epileptic drugs at

National Referral Hospitals in Uganda: a cross-sectional study’, Health and quality of life outcomes, 12, pp. 49–49. doi: 10.1186/1477-7525-12-49.

Norsa’adah, B., Zainab, J. and Knight, A. (2013) ‘The quality of life of people with epilepsy at a tertiary referral centre in Malaysia’, Health and quality of life outcomes, 11, pp. 143–143. doi: 10.1186/1477-7525-11-143.

Panebianco, M., Rigby, A. and Marson, A. G. (2022) ‘Vagus nerve stimulation for focal seizures’, The Cochrane database of systematic reviews, 7(7), pp. CD002896–CD002896. doi: 10.1002/14651858.CD002896.pub3.

Rakesh, P. S. et al. (2012) ‘Quality of life among people with epilepsy: a cross-sectional study from rural southern India’, The National Medical Journal of India, 25(5), pp. 261–264.

Ridsdale, L. et al. (2017) ‘Characteristics associated with quality of life among people with drug-resistant epilepsy’, Journal of neurology. 2017/05/26 edn, 264(6), pp. 1174– 1184. doi: 10.1007/s00415-017-8512-1.

Saadi, A. et al. (2016) ‘Quality of life in epilepsy in Bhutan’, Seizure, 39, pp. 44–48. doi: 10.1016/j.seizure.2016.05.001. 23. Saadi, A., Patenaude, B. and Mateen, F. J. (2016) ‘Quality of life in epilepsy—31 inventory (QOLIE-31) scores: A global comparison’, Epilepsy & Behavior, 65, pp. 13–17. doi: 10.1016/j.yebeh.2016.09.032.

Sauer, V. et al. (2024) ‘Favorable combinations of antiseizure medication with vagus nerve stimulation to improve health related quality of life in patients with epilepsy’, Epilepsy & Behavior, 150, p. 109562. doi: 10.1016/j.yebeh.2023.109562.

Shakirullah et al. (2014) ‘The prevalence, incidence and etiology of epilepsy’, International Journal of Clinical and Experimental Neurology, 2(2), pp. 29–39. doi: 10.12691/ ijcen-2-2-3.

Shlobin, N. A. et al. (2022) ‘Ethical considerations in the surgical and neuromodulatory treatment of epilepsy’, Epilepsy & Behavior, 127, p. 108524. doi: 10.1016/j. yebeh.2021.108524.

Singh, P. and Pandey, A. K. (2017) ‘Quality of life in epilepsy’, International Journal of Research in Medical Sciences, 5(2), p. 452. doi: 10.18203/2320-6012.ijrms20170024.

Siqueira, N. F. et al. (2014) ‘Quality of life in epilepsy: a study of Brazilian adolescents’, PloS one, 9(9), pp. e106879– e106879. doi: 10.1371/journal.pone.0106879.

Skrehot, H. C., Englot, D. J. and Haneef, Z. (2023) ‘Neuro stimulation in focal epilepsy: A systematic review and meta-analysis’, Epilepsy & Behavior, 142, p. 109182. doi: 10.1016/j.yebeh.2023.109182.

Staniszewska, A., Kurkowska-Jastrzębska, I. and Tarchalska Kryńska, B. (2015) ‘Quality of life in patients with epilepsy’, Journal of Public Health, Nursing and Medical Rescue (JPHNMR), 157(3), pp. 20–26.

Tedrus, G. M. A. S., Limongi, J. M. and Zuntini, J. V. R. (2020) ‘Resilience, quality of life, and clinical aspects of patients with epilepsy’, Epilepsy & Behavior, 103, p. 106398. doi: 10.1016/j.yebeh.2019.06.041.

Thijs, R. D. et al. (2019) ‘Epilepsy in adults’, The Lancet, 393(10172), pp. 689–701. doi: 10.1016/s0140- 6736(18)32596-0.

Tombini, M. et al. (2021) ‘Epilepsy and quality of life: what does really matter?’, Neurological Sciences, 42(9), pp. 3757–3765. doi: 10.1007/s10072-020-04990-6.

Verrotti, A. et al. (2019) ‘The role of polytherapy in the management of epilepsy: suggestions for rational antiepileptic drug selection’, Expert Review of Neurotherapeutics, 20(2), pp. 167–173. doi: 10.1080/14737175.2020.1707668.

Winter, Y. et al. (2018) ‘Health-related quality of life in patients with poststroke epilepsy’, Epilepsy & Behavior, 80, pp. 303–306. doi: 10.1016/j.yebeh.2017.12.037.

Winter, Y. et al. (2023) ‘Synergistic effects of vagus nerve stimulation and antiseizure medication’, Journal of neurology. 2023/06/27 edn, 270(10), pp. 4978–4984. doi: 10.1007/s00415-023-11825-9.

World Health Organization, D. of M. H. and P. of S. A. (1997) ‘WHOQOL : measuring quality of life’. Available at: https://iris.who.int/handle/10665/63482 (Accessed: 18 May 2024).

Yogarajah, M. and Mula, M. (2019) ‘Social cognition, psychiatric comorbidities, and quality of life in adults with epilepsy’, Epilepsy & Behavior, 100, p. 106321. doi: 10.1016/j.yebeh.2019.05.017.

Downloads

Published

2024-07-04

How to Cite

Turke, A. F. A., & Majeed, H. M. (2024). Quality of Life among Epileptic Patients after Vagus Nerve Stimulator Implan tation: A Cross-Sectional Study . Journal of Indian Academy of Forensic Medicine, 46((1-Suppl), 202-206. https://doi.org/10.48165/jiafm.2024.46.1(Suppl).24